Clinical Trials Browser

Phase 2 × Terminated × 4-fluorobenzoyl-TN-14003 × Clear all

NCT02763384 2023-10-31

BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

Phase 2 Terminated

12 enrolled 14 charts

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma